Jbf Capital, Inc. Catalyst Pharmaceuticals, Inc. Transaction History

Jbf Capital, Inc.

3 transactions

Quarter	Operation	Price Per share	shares change	shares Held
Q4 2018 Feb 12, 2019	SELL	$1.92 - $3.62 $976,512 - $1.84 Million	-508,600 Closed	0 $0
Q2 2018 Aug 09, 2018	BUY	$2.26 - $3.84 $112,999 - $192,000	50,000 Added 10.9%	508,600 $1.59 Million
Q1 2018 May 11, 2018	BUY	$2.39 - $4.01 $1.1 Million - $1.84 Million	458,600 New	458,600 $1.1 Million

277

95.7M

40.6K

67.2K

Ticker CPRX
Exchange NASDAQ
Sector Healthcare
Industry Biotechnology
Shares Outstandng 102,820,000
Market Cap $1.62B
Description
Catalyst Pharmaceuticals, Inc., a commercial-stage biopharmaceutical company, focuses on developing and commercializing therapies for people with rare debilitating, chronic neuromuscular, and neurological diseases in the United States. It offers Firdapse, an amifampridine phosphate tablets for the treatment of patients with lambert-eaton myasthe...

Get notified when there are updates to the investment portfolio of Jbf Capital, Inc., based on Form 13F filings with the SEC.

Stay updated on Jbf Capital, Inc. with notifications on news.